Delegation from Lower Silesia tours Potsdam Science Hub - Dutch representatives tour Potsdam Science Park
In the heart of Potsdam, Brandenburg, two pioneering start-ups, CanChip and kez.biosolutions, showcased their groundbreaking innovations in cancer research and biotechnology. The event, which took place at the Science Park, brought together a delegation to discuss potential innovation and transfer projects between Brandenburg and Lower Silesia, Poland.
The discussion focused on fields such as medical technology, digital health, and AI-assisted diagnostics, areas that have been prioritized in the Polish-German Forum and Innovation Cooperation. This collaboration, which has been rekindled after a seven-year hiatus, aims to address critical issues and foster joint solutions, particularly under the Weimar Triangle framework.
Both regions have substantial research institutions and clusters focusing on AI, digitalization, and healthcare innovation, providing a strong basis for joint project development. Partnerships could involve universities, research institutes, and companies in Brandenburg and Lower Silesia facilitating technology transfer and innovation scaling.
The intersection of digital health and AI diagnostics is a natural fit for regional innovation strategies, given the strong scientific and industrial bases in both regions. Collaborative projects could leverage smart health technologies, sensor technology, and AI for diagnostics, aligning with EU regional funding priorities and innovation agendas.
Programs and projects like P1 Smart and VReduMED (a project in Bavaria focusing on medical technologies and sensor innovations) illustrate the type of cross-border collaboration possible in Central Europe. Brandenburg and Lower Silesia may benefit from similar Interreg and other EU funding opportunities aimed at promoting sustainable innovation in health technologies and AI-enabled diagnostics.
Engagement through the Polish-German Forum and similar platforms could further enhance information exchange and identify concrete collaborative projects. For detailed contacts or current open calls, stakeholders would typically find such information through regional development agencies or EU cross-border cooperation portals.
Agnes von Matuschka, the managing director of the park, was present at the event, overseeing the discussions and potential collaborations that could shape the future of cancer research and biotechnology. The exact members of the delegation were not specified, but their shared commitment to innovation and collaboration was evident.
- The discussion within the delegation, given the focus on medical technology, digital health, and AI-assisted diagnostics, might consider expanding the scope of vocational training to incorporate emerging technology skills, such as computer science and AI, in line with the community policy of both regions.
- In line with the intersection of digital health and AI diagnostics being a priority for regional innovation strategies, joint projects could potentially incorporate vocational training programs in science and technology, with a focus on medical conditions and advances in biotechnology, similar to the initiatives seen in projects like P1 Smart and VReduMED.
